Diffusion imaging changes in grey matter in Alzheimer’s disease: a potential marker of early neurodegeneration

Alzheimer’s disease (AD) is recognized to have a long presymptomatic period, during which there is progressive accumulation of molecular pathology, followed by inexorable neuronal damage. The ability to identify presymptomatic individuals with evidence of neurodegenerative change, to stage their dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Weston, Philip S.J., Simpson, Ivor J.A., Ryan, Natalie S., Ourselin, Sebastien, Fox, Nick C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487800/
https://www.ncbi.nlm.nih.gov/pubmed/26136857
http://dx.doi.org/10.1186/s13195-015-0132-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487800/
https://www.ncbi.nlm.nih.gov/pubmed/26136857
http://dx.doi.org/10.1186/s13195-015-0132-3

Ejemplares similares